Harald Gschaidmeier
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Genetic and Kidney Cyst Diseases
Papers in
- Hematology 32
- Chronic Myeloid Leukemia Treatments 31
- Genetics 21
- Chronic Lymphocytic Leukemia Research 18
- Co-authors
- Oliver G. Ottmann (16 shared papers)Andreas Hochhaus (12 shared papers)Karl Walter Bock (10 shared papers)Dieter Hoelzer (10 shared papers)Tanja Lahaye (6 shared papers)Rüdiger Hehlmann (6 shared papers)Sebastian Kreil (6 shared papers)Claudia Schoch (5 shared papers)
- Journals
- Blood (11 papers)Leukemia (9 papers)Biochemical Pharmacology (4 papers)Journal of Clinical Investigation (3 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Harald Gschaidmeier
54 papers receiving 4.3k citations
Harald Gschaidmeier's Hit Papers
Peers
Comparison fields: 5 of 111
- Hematology 2.0k
- Genetics 1.2k
- Transplantation 209
- Rheumatology 928
- Pharmacology 274
Countries citing papers authored by Harald Gschaidmeier
This map shows the geographic impact of Harald Gschaidmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Gschaidmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Gschaidmeier more than expected).
Fields of papers citing papers by Harald Gschaidmeier
This network shows the impact of papers produced by Harald Gschaidmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Gschaidmeier. The network helps show where Harald Gschaidmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Harald Gschaidmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy Hit paper breakdown → | 2002 | 679 |
| 2 | 2010 | 436 | |
| 3 | 2002 | 304 | |
| 4 | 2002 | 287 | |
| 5 | 2011 | 274 | |
| 6 | 2002 | 205 | |
| 7 | 2007 | 177 | |
| 8 | 2002 | 158 | |
| 9 | 2005 | 151 | |
| 10 | 1993 | 126 | |
| 11 | 2002 | 124 | |
| 12 | 2002 | 109 | |
| 13 | 2004 | 108 | |
| 14 | 2003 | 91 | |
| 15 | Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. | 2003 | 77 |
| 16 | 2003 | 65 | |
| 17 | 2005 | 65 | |
| 18 | 2005 | 61 | |
| 19 | 1999 | 61 | |
| 20 | 2002 | 58 |
About Harald Gschaidmeier
Harald Gschaidmeier is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Oncology, having authored 54 papers that have together received 4.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (31 papers), Eosinophilic Disorders and Syndromes (19 papers), Chronic Lymphocytic Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (15 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (5 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (1.2k citations), Transplantation (209 citations), Rheumatology (928 citations) and Pharmacology (274 citations). Harald Gschaidmeier has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Oliver G. Ottmann, Andreas Hochhaus, Karl Walter Bock, Dieter Hoelzer, Tanja Lahaye, Rüdiger Hehlmann, Sebastian Kreil, Claudia Schoch, H. Phillip Koeffler and Ute Berger. Their work appears in journals such as Blood, Leukemia, Biochemical Pharmacology, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.